茵栀黄联合妈咪爱对新生儿高胆红素血症疗效的观察

The efficacy of Yinzhihuang and Medilac-Vita as adjunctive treatment in the neonate with hyperbilirubinemia

目的:观察茵栀黄颗粒联合妈咪爱散剂辅助治疗新生儿高胆红素血症的疗效。方法:将122例新生儿高胆红素血症患儿随机分为两组,对照组接受蓝光及苯巴比妥等常规治疗,观察组在常规治疗基础上加用茵栀黄颗粒和妈咪爱散剂,对治疗前后的血清总胆红素水平进行观察比较。结果:观察组患儿的日均胆红素下降值及总胆红素下降值与对照组比较,差异有统计学意义(P<0.05)。结论:在常规治疗基础上配合茵栀黄、妈咪爱治疗新生儿高胆红素血症简单方便,安全有效。

Objective： To observe the clinical effect of Yinzhihuang Keli and Medilac-Vita as adjunctive treatment in the neonate with hyperbilirubinemia. Methods： 122 cases of neonate with hyperbilirubinemia were randomly separated into two groups, which control group（60 cases） were taken normal nursing and observation group（62 cases）were taken additional pharmacotherapy including Yinzhihuang and Medilac-Vita on the base of routing drug treatment. Results： The level of bilirubin of the neonates in the observation group was obviously lower than which of the control group （P〈0.05）. Conclusion： Appropriate adjunctive treatment for neonate with hyperbilirubinemia can decline the level of bilirobin.